John Zechner & other talkHe has been buyingVRX...who knew!!!! Well that's something & maybe the trickle down will positively affect CXR eventually.
why have the option to buy Philio at all (OLeary).
O'Leary also mentioned that VRX is the subject of conversation everywhere (& what not to do) & Burrows said that VRX is an interesting case.... IMO....probably a test case or study case for business schools; whereby access for money is being restricted for all those
who grow by acquisistion. Eventually growth by acquisition fails as each acquisition has to be bigger & biger to pay for the next one & maybe for VRX that time has come & maybe for CXR its lifespan of doing the same thing has been shortened!!
The days of price increases to the extent that they have happened in the past are over!!!!
And if that model is broken growth by acquisition will take a hit until the next business cycle or maybe forever.... if Hiliary gets in as she has it in for the biotech sector & even though getting legislation passed maybe problematic...the worry that there may be a compromise on how much increase will be allowed.
People like Left do not have to be right at the end of the day.
carlos